Women That Take Truvada And Depo Provera May Experience Double Bone Density Loss

Depot medroxyprogesterone acetate (DMPA), also known as Depo Provera, is a widely used injectable contraceptive that a study shows intensifies Truvada bone density loss


Truvada Bone Lawsuit News

Wednesday, February 3, 2021 - People living with AIDS (PLWA) look to the side effects of taking their antiretroviral cocktail of health management drugs seriously. PLWA knows that taking Truvada causes kidney damage and bone density weakness. PLWA have a much different agenda than LGBTQ activists that are trying their best to stop the spread of HIV and possibly eliminate the disease. Starting in 2019, the LGBTQ community ignored the potentially devastating side effects that users of Truvada, also known as tenofovir disoproxil fumarate (TDF) have experienced when the group sought to have social media remove attorney advertising for clients that had bone density loss after taking the drug. LGBTQ groups pontificated that attorney advertising was overstating Truvada's side effects and scaring HIV negative people in a sexual relationship with an infected partner from taking Truvada to prevent the spread. Truvada is free to HIV negative individuals that qualify. Truvada has proven to be 99 percent effective in stopping the spread of AIDS when taken daily and used in conjunction with a condom and limiting sexual activity to a one-on-one relationship. The LGBTQ community wants as many people as possible to consider taking Truvada and to do so responsibly. Truvada's side effects of bone density loss seem to affect people that are taking the drug for the management of existing AIDS conditions and also are the very young with developing bone density and very old that suffer from bone density loss. In effect, Truvada may prevent proper bone development in young people and exacerbate bone density loss in the elderly. Bone density loss may also increase if one is using Truvada and also taking the injectable hormonal contraceptive Depo Provera.

According to an article on AidsMap.com, those who take Truvada for AIDS management or as a prophylactic are twice as likely to develop catastrophic bone density loss that could lead to bone fractures from everyday physical activity. Authors write, "Use of the injectable hormonal contraceptive Depo Provera was associated with a doubling of bone loss in young women starting antiretroviral treatment containing tenofovir disoproxil fumarate (TDF), according to a study presented this week at the 23rd International AIDS Conference (AIDS 2020: Virtual)." It is interesting to note that bone tissue is in a constant state of flux and naturally deteriorates and replenishes. Taking Truvada may interfere with this process and taking DP only intensifies the problem. "Bone tissue is continually produced and reabsorbed. Loss of bone mineral density occurs when reabsorption outstrips bone formation. Depo Provera leads to lower estrogen levels that can promote loss of bone density, as seen in women after the menopause." Individuals that have suffered the catastrophic bone density loss from taking Truvada have hired Truvada Bone Loss Attorneys to help in filing a claim against Gilead Sciences, the maker of Truvada, for failing to warn them of Truvada's side effects.

More Recent Truvada Bone Lawsuit News:

No-Cost, No-Obligation Truvada Lawsuit Case Review If You or a Loved One Suffered from Truvada Bone or Kidney Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.